ILC Dover, a US innovative design and manufacturer of engineered products, and portfolio company of New York-based investment firm New Mountain Capital is set to acquire Flexan, an Illinois-headquartered medical device contract design and manufacturing company that specialises in silicone, thermoplastic, and specialty rubber components and devices. The transaction is expected to close by August 2021.
This is the second acquisition ILC Dover has completed since its partnership with New Mountain Capital in early 2020. The acquisition is expected to grow ILC Dover’s life sciences solutions for its global customer base, including the pharmaceutical and biopharmaceutical end markets.
Flexan, founded in 1946, and ILC Dover’s partnership is expected to leverage their respective expertise and capabilities to serve a broader client base in both medical device and biopharmaceutical end markets.